Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
Condition | Onset Date | Status |
---|---|---|
Nonproliferative retinopathy due to type 2 diabetes mellitus | 2020-02-11 | active |
Ischemic heart disease | 2019-02-05 | active |
Chronic sinusitis | 2013-05-11 | active |
Hyperlipidemia | 2010-12-21 | active |
Retinopathy due to type 2 diabetes mellitus | 2008-07-01 | active |
Hyperglycemia | 1998-10-13 | active |
Metabolic syndrome X | 1998-10-13 | active |
Hypertriglyceridemia | 1998-10-13 | active |
Type 2 diabetes mellitus | 1997-10-07 | active |
Prediabetes | 1984-09-11 | active |
Anemia | 1984-09-11 | active |
Medication | Since | Form | Dosage | Reason |
---|---|---|---|---|
Simvastatin 10 mg oral tablet | 2025-03-18 | Oral tablet | 1 tablet (10 mg) by mouth once daily | Hyperlipidemia |
Metformin hydrochloride 500 mg prolonged-release oral tablet | 2025-03-11 | Prolonged-release oral tablet | 1 tablet (500 mg) once daily | Diabetes mellitus type 2 (disorder) |
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet | 2019-02-12 | Oral tablet | 1 tablet (75 mg) once daily | |
Simvastatin 20 mg oral tablet | 2019-02-12 | Oral tablet | 1 tablet (20 mg) by mouth once daily | |
Nitroglycerin 400 microgram/actuation sublingual spray | 2019-02-12 | Sublingual spray | 400 micrograms (1 spray) sublingually as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes | |
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet | 2019-02-12 | Prolonged-release oral tablet | 1 tablet (100 mg) once daily |
No known allergies or intolerances |
Procedure | Date | Reason |
---|---|---|
Medication reconciliation | 2021-04-27 | - |
Vaccine | Date |
---|---|
Influenza virus antigen only vaccine product | 2025-03-11 |
Clostridium tetani toxoid antigen adsorbed only vaccine product | 2022-02-22 |
SARS-CoV-2 mRNA vaccine | 2021-03-30 |
Immunization Recommendation | Due Date | Reason |
---|---|---|
Vaccine product containing only Influenza virus antigen (medicinal product) | 2025-10-01 | Annual seasonal influenza vaccination |
Condition | Period | Status |
---|---|---|
Acute viral pharyngitis | 2021-04-10 – 2021-04-23 | inactive |
Vital Signs | 2025-03-11 | 2024-03-05 |
---|---|---|
Body Height | 174.6 cm | 174.6 cm |
Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 {score} | 1 {score} |
Body Weight | 86.9 kg | 85.1 kg |
Body mass index (BMI) [Ratio] | 28.5 kg/m2 | 27.9 kg/m2 |
Diastolic Blood Pressure | 77 mm[Hg] | 70 mm[Hg] |
Systolic Blood Pressure | 114 mm[Hg] | 110 mm[Hg] |
Heart rate | 69 /min | 71 /min |
Respiratory rate | 16 /min | 13 /min |